These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 8547667)

  • 21. Hematopoietic Stem Cell Transplant in Adolescent and Young Adults With Fanconi Anemia Is Feasible With Acceptable Toxicity, With Those Surviving 100 Days Posttransplant Having Excellent Outcomes.
    Alhuraiji A; Alzahrani H; Al Mohareb F; Chaudhri N; Alsharif F; Mohamed S; Rasheed W; Aldawsari G; Ahmed SO; Aljurf M
    Exp Clin Transplant; 2016 Dec; 14(6):660-664. PubMed ID: 27447289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of Fanconi anemia by bone marrow transplantation].
    Friedrich W; Ebell W; Blütters-Sawatzki R; Junker A; Hübener KH; Schroeder-Kurth T; Kohne E; Kleihauer E
    Monatsschr Kinderheilkd; 1987 May; 135(5):253-8. PubMed ID: 3302684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome after marrow transplantation for severe aplastic anemia.
    Deeg HJ; Leisenring W; Storb R; Nims J; Flowers ME; Witherspoon RP; Sanders J; Sullivan KM
    Blood; 1998 May; 91(10):3637-45. PubMed ID: 9572999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.
    Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow transplantation in Fanconi anaemia.
    Gluckman E; Devergie A; Schaison G; Bussel A; Berger R; Sohier J; Bernard J
    Br J Haematol; 1980 Aug; 45(4):557-64. PubMed ID: 7000153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.
    Mehta PA; Davies SM; Leemhuis T; Myers K; Kernan NA; Prockop SE; Scaradavou A; O'Reilly RJ; Williams DA; Lehmann L; Guinan E; Margolis D; Baker KS; Lane A; Boulad F
    Blood; 2017 Apr; 129(16):2308-2315. PubMed ID: 28179273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.
    Min CK; Kim DW; Lee JW; Min WS; Kim CC
    Acta Haematol; 2000; 104(4):185-92. PubMed ID: 11279309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fanconi's anemia treated by allogeneic marrow transplantation.
    Deeg HJ; Storb R; Thomas ED; Appelbaum F; Buckner CD; Clift RA; Doney K; Johnson L; Sanders JE; Stewart P; Sullivan KM; Witherspoon RP
    Blood; 1983 May; 61(5):954-9. PubMed ID: 6338978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low risk of graft-versus-host disease with transplantation of CD34 selected peripheral blood progenitor cells from alternative donors for Fanconi anemia.
    Boyer MW; Gross TG; Loechelt B; Leemhuis T; Filipovich A; Harris RE
    J Pediatr Hematol Oncol; 2003 Nov; 25(11):890-5. PubMed ID: 14608200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia.
    Socié G; Henry-Amar M; Cosset JM; Devergie A; Girinsky T; Gluckman E
    Blood; 1991 Jul; 78(2):277-9. PubMed ID: 2070065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens.
    Pasquini R; Carreras J; Pasquini MC; Camitta BM; Fasth AL; Hale GA; Harris RE; Marsh JC; Robinson AJ; Zhang MJ; Eapen M; Wagner JE
    Biol Blood Marrow Transplant; 2008 Oct; 14(10):1141-1147. PubMed ID: 18804044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow transplantation in pediatric patients with severe aplastic anemia: cyclophosphamide and anti-thymocyte globulin conditioning followed by recombinant human granulocyte-macrophage colony stimulating factor.
    Bunin N; Leahey A; Kamani N; August C
    J Pediatr Hematol Oncol; 1996 Feb; 18(1):68-71. PubMed ID: 8556374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow transplantation in Fanconi anemia using matched sibling donors.
    Kohli-Kumar M; Morris C; DeLaat C; Sambrano J; Masterson M; Mueller R; Shahidi NT; Yanik G; Desantes K; Friedman DJ
    Blood; 1994 Sep; 84(6):2050-4. PubMed ID: 8081006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
    Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
    Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience.
    Flowers ME; Doney KC; Storb R; Deeg HJ; Sanders JE; Sullivan KM; Bryant E; Witherspoon RP; Appelbaum FR; Buckner CD
    Bone Marrow Transplant; 1992 Mar; 9(3):167-73. PubMed ID: 1511254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
    Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
    J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful bone marrow transplantation in sensitized aplastic anemia patients using total lymphoid irradiation for conditioning: long-term follow-up.
    Zapatero A; Marín A; López M; Martín De Vidales C; Cerezo L; Domínguez P; Pérez Torrubia A
    Hematol Oncol; 1996 Dec; 14(4):165-72. PubMed ID: 9267462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of graft vs host disease in allogeneic bone marrow transplantation in a single center study from Turkey.
    Ilhan O; Akan H; Koç H; Gürman G; Arslan O; Ozcan M; Erdi H; Erdem C; Konuk N; Uysal A; Beksaç M
    Hematol Cell Ther; 1997 Jun; 39(3):133-6. PubMed ID: 9262989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow transplantation for patients with acquired severe aplastic anemia using cyclophosphamide and antithymocyte globulin: the experience from a single center.
    Abdelkefi A; Ben Othman T; Ladeb S; Torjman L; Hsaïri M; Ben Abdeladhim A
    Hematol J; 2003; 4(3):208-13. PubMed ID: 12764353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
    Tan PL; Wagner JE; Auerbach AD; Defor TE; Slungaard A; Macmillan ML
    Pediatr Blood Cancer; 2006 May; 46(5):630-6. PubMed ID: 16078221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.